Signals from a pivotal trial now cut through the noise of a crowded obesity market, forcing hard questions about where dual agonists belong and how quickly they can reshape care. Obesity has shifted from a lifestyle narrative to a biologic disease with organ-level consequences, most notably in the
Matthias Aizenberg sits down with Ivan Kairatov, a biopharma expert whose work straddles gene editing and viral delivery, to unpack a new way of building better gene-editing vehicles by rethinking the cells that make them. Rather than only re-engineering virus-like particles, his team interrogated
The landscape of global pharmaceuticals is currently witnessing a profound architectural shift as legacy regulatory frameworks, once characterized by redundant clinical hurdles, give way to a streamlined, evidence-based approach designed to democratize access to biological therapies. For several
The recent breakthrough in oncological research has shifted the paradigm from analyzing what a tumor is composed of to understanding exactly how its internal components are physically positioned. Researchers at the UCLA Health Jonsson Comprehensive Cancer Center have identified that the spatial
The abrupt cessation of nearly eight hundred million dollars in federal support has forced a paradigm shift in how the pharmaceutical industry approaches pandemic preparedness and biotechnological research. The landscape of global health security is currently witnessing a high-stakes test of
The global dietary landscape is currently undergoing a significant transition as consumers increasingly pivot toward plant-based dairy alternatives that offer more than just basic caloric value. This movement is no longer characterized merely by the search for a milk substitute but has evolved into
